EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabidiol dose dependently reduces alcohol intake in mice via a non‐5‐HT 1A receptor mechanism: Exploration of other potential receptor targets

Connie J Badolato iD, Erin A Lynch, Jonathon C Arnold, Iain S McGregor, Michael T Bowen

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Connie J Badolato und 4 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia. Hauptthemen laut MEDLINE: Cannabidiol, Receptor, Serotonin, 5-HT1A, Alcohol Drinking. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lambert Family to The University of Sydney, Australian National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Binge drinking is a risky pattern of alcohol intake and a major predictor of alcohol use disorder (AUD). Current AUD medications have limited efficacy and poor patient compliance, calling for more effective therapeutics. Cannabidiol (CBD), a non‐intoxicating component of cannabis, has emerged as a potential novel therapeutic. However, receptor mechanisms in CBD's alcohol‐related effects have not been investigated comprehensively. Experimental Approach Using the murine drinking‐in‐the‐dark model of binge drinking, our research aimed to confirm a reduction of alcohol consumption with CBD (7.5, 15, 30, 60, 120 mg kg −1 ) in male and female mice. Behavioural pharmacological approaches were used to explore CBD interactions with identified target mechanisms: serotonin‐1A receptor (5‐HT 1A R) and peroxisome proliferator‐activated receptor‐gamma (PPARɣ), and the novel targets, chemokine receptor type‐4 (CXCR4) and neuropeptide S receptor (NPSR). Key Results Acute CBD dose dependently suppressed binge‐like drinking and blood ethanol concentration. The effect was not driven by locomotor impairments and was maintained across sub‐chronic treatment. Blockade of 5‐HT 1A R and PPARɣ had no impact on CBD's reduction of alcohol consumption. Co‐administration of subthreshold CBD doses and a NPSR antagonist implicated NPSR blockade as a potential mechanism contributing to CBD's effect, whereas co‐administration of CBD and a CXCR4 antagonist suggested CXCR4 was not involved. However, the potent and selective CXCR4 antagonist AMD3100 reduced ethanol consumption. Conclusions and Implications CBD represents a promising candidate to reduce voluntary alcohol consumption. Mechanisms driving CBD's alcohol‐related effects remain unclear and may involve polypharmacology, including actions at the NPSR identified in the present study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolReceptor, Serotonin, 5-HT1AAlcohol DrinkingAnimalsMaleMiceFemaleDose-Response Relationship, DrugMice, Inbred C57BLEthanolPPAR gamma

Stichwörter der Autor:innen

alcohol use disordercannabidiolchemokine receptor type 4drinking‐in‐the‐darkneuropeptide S receptorperoxisome proliferator‐activated receptor‐gammaserotonin‐1A receptor

Substanzen

CannabidiolReceptor, Serotonin, 5-HT1AEthanolPPAR gamma

Autor:innen und Institutionen

  • Brain and Mind Centre, The University of Sydney, Camperdown, New South Wales, Australia.
  • Faculty of Science, School of Psychology, The University of Sydney, Camperdown, New South Wales, Australia.
  • Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Camperdown, New South Wales, Australia.
  • Faculty of Medicine and Health, Sydney Pharmacy School, The University of Sydney, Camperdown, New South Wales, Australia.

ORCID-Profile: Connie J Badolato

Förderung

  • Lambert Family to The University of Sydney
  • Australian National Health and Medical Research Council

Zitieren

APA

Badolato, C. J., Lynch, E. A., Arnold, J. C., McGregor, I. S., & Bowen, M. T. (2025). Cannabidiol dose dependently reduces alcohol intake in mice via a non‐5‐HT 1A receptor mechanism: Exploration of other potential receptor targets. British Journal of Pharmacology. https://doi.org/10.1111/bph.70070

Vancouver

Badolato CJ, Lynch EA, Arnold JC, McGregor IS, Bowen MT. Cannabidiol dose dependently reduces alcohol intake in mice via a non‐5‐HT 1A receptor mechanism: Exploration of other potential receptor targets. British Journal of Pharmacology. 2025. doi:10.1111/bph.70070

BibTeX
@article{Badolato2025,
  author = {Badolato, Connie J and Lynch, Erin A and Arnold, Jonathon C and McGregor, Iain S and Bowen, Michael T},
  title = {Cannabidiol dose dependently reduces alcohol intake in mice via a non‐5‐HT 1A receptor mechanism: Exploration of other potential receptor targets},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70070}
}
Kostenlos starten →